JPWO2023190300A1 - - Google Patents

Info

Publication number
JPWO2023190300A1
JPWO2023190300A1 JP2024512437A JP2024512437A JPWO2023190300A1 JP WO2023190300 A1 JPWO2023190300 A1 JP WO2023190300A1 JP 2024512437 A JP2024512437 A JP 2024512437A JP 2024512437 A JP2024512437 A JP 2024512437A JP WO2023190300 A1 JPWO2023190300 A1 JP WO2023190300A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024512437A
Other languages
Japanese (ja)
Other versions
JPWO2023190300A5 (https=
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2023190300A1 publication Critical patent/JPWO2023190300A1/ja
Publication of JPWO2023190300A5 publication Critical patent/JPWO2023190300A5/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/40Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41Glycosylation, sialylation, or fucosylation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/34Sugars

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2024512437A 2022-03-28 2023-03-27 Pending JPWO2023190300A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022051206 2022-03-28
PCT/JP2023/012126 WO2023190300A1 (ja) 2022-03-28 2023-03-27 生産物の生産方法、及び生産物

Publications (2)

Publication Number Publication Date
JPWO2023190300A1 true JPWO2023190300A1 (https=) 2023-10-05
JPWO2023190300A5 JPWO2023190300A5 (https=) 2025-01-08

Family

ID=88201646

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024512437A Pending JPWO2023190300A1 (https=) 2022-03-28 2023-03-27

Country Status (5)

Country Link
US (1) US20250019419A1 (https=)
EP (1) EP4502169A4 (https=)
JP (1) JPWO2023190300A1 (https=)
CN (1) CN118974267A (https=)
WO (1) WO2023190300A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021097281A1 (en) 2019-11-15 2021-05-20 Lonza Ltd Process and system for producing an inoculum
JPWO2023190829A1 (https=) * 2022-03-31 2023-10-05
WO2025181869A1 (ja) * 2024-02-26 2025-09-04 中外製薬株式会社 細胞培養方法及びシステム

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2493922T1 (sl) * 2009-10-26 2017-06-30 F. Hoffmann-La Roche Ag Postopek za proizvodnjo glikoziliranega imunoglobulina
AU2014226126B2 (en) 2013-03-08 2019-02-14 Genzyme Corporation Continuous purification of therapeutic proteins
US9873891B2 (en) 2013-05-03 2018-01-23 Fujifilm Diosynth Biotechnologies Uk Limited Expression process
JP2020533983A (ja) 2017-09-15 2020-11-26 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company 目的のポリペプチドのラージスケールの製造間のオンラインバイオマス静電容量モニタリング
AU2018383679B2 (en) 2017-12-11 2025-10-09 Amgen Inc. Continuous manufacturing process for bispecific antibody products
JP2020005511A (ja) * 2018-07-03 2020-01-16 株式会社日立製作所 培養方法及び培養装置

Also Published As

Publication number Publication date
WO2023190300A1 (ja) 2023-10-05
CN118974267A (zh) 2024-11-15
EP4502169A4 (en) 2025-12-31
US20250019419A1 (en) 2025-01-16
EP4502169A1 (en) 2025-02-05

Similar Documents

Publication Publication Date Title
JPWO2023190300A1 (https=)
BR102022025291A2 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001987A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13141U (https=)
BY13152U (https=)
BY13136U (https=)
BY13137U (https=)
BY13138U (https=)
BY13139U (https=)
BY13140U (https=)
CN307048992S (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240918

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260204